Back

Management of ATTR-CM: from clinical trial data to real-world evidence

12 May 2024 (13:00 - 13:15)
Organised by: Logo
Congress Presentation Part of: Applying ATTR-CM data for optimal outcomes: from trials to clinical practice Cardiac Amyloidosis HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Professor Stefano Perlini

University of Pavia, Pavia (Italy)

3 More presentations in this session

Presentation thumbnail
Uncovering a hidden cause of heart failure in your patients
Assistant Professor D. Brito (Lisbon, PT)
Slides
Presentation thumbnail
Multidisciplinary collaboration for optimal outcomes in ATTR-CM
Doctor R. Eiros (Salamanca, ES)
Slides
Presentation thumbnail
Q&A

Access the full session

Session thumbnail
Applying ATTR-CM data for optimal outcomes: from trials to clinical practice
Video

The Event

Event poster

Heart Failure 2024

12 May 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Clinical presentation and treatment landscape of patients with transthyretin amyloidosis with cardiomyopathy: a real-world study in five European countries and Japan
18 May 2025
thumbnail
Congress Session
Evolving treatment paradigms in heart failure: from SGLT2 inhibition to transthyretin stabilisation and beyond
20 May 2025
thumbnail
Congress Presentation
Amyloid progression or comorbidities? Differentiating management for optimal outcomes
31 August 2025
thumbnail
Congress Presentation
Exploring ATTR cardiomyopathy: the journey to improved outcomes
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources